Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | LMNA | P02545 | 4/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.47 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.43 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.43 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.43 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.41 |
| ▸ | INPP5A | Q14642 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2935357 | 1.00 | ALDH1A1 (0.57) | ALDH1A1LMNAMEN1KMT2AKDM4E | |
| SCHEMBL9484139 | 0.90 | ALDH1A1 (0.57) | ALDH1A1LMNAMEN1KMT2AKDM4E | |
| SCHEMBL8988924 | 0.87 | ALDH1A1 (0.52) | ALDH1A1LMNAMEN1KMT2AKDM4E | |
| SCHEMBL15647383 | 0.87 | ALDH1A1 (0.52) | ALDH1A1LMNAMEN1KMT2AKDM4E | |
| SCHEMBL8988670 | 0.87 | ALDH1A1 (0.52) | ALDH1A1LMNAMEN1KMT2AKDM4E | |
| SCHEMBL8988919 | 0.87 | ALDH1A1 (0.55) | ALDH1A1LMNAMEN1KMT2AKDM4E | |
| SCHEMBL11352601 | 0.86 | ALDH1A1 (0.60) | ALDH1A1LMNAMEN1KMT2AKDM4E | |
| SCHEMBL8987733 | 0.85 | ALDH1A1 (0.50) | ALDH1A1LMNAMEN1KMT2AKDM4E | |
| Citric Acid SCHEMBL8988622 | 0.83 | ALDH1A1 (0.46) | ALDH1A1LMNAMEN1KMT2AKDM4E | |
| SCHEMBL8988667 | 0.83 | ALDH1A1 (0.57) | ALDH1A1LMNAMEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6916463-B2 | Oral products having an aesthetic layer | THE PROCTER & GAMBLE COMPANY (US) | 2005-07-12 | — | — | US | claimed |
| US-20040057910-A1 | Oral products having an aesthetic layer | THE PROCTER & GAMBLECOMPANY | 2004-03-25 | — | — | US | claimed |
| CN-101909582-A | Oral care delivery system with microcrystalline wax | PROCTER & GAMBLE | 2010-12-08 | — | — | CN | disclosed |
| EP-2227214-A1 | ORAL CARE DELIVERY SYSTEM WITH MICROCRYSTALLINE WAX | The Procter & Gamble Company (US) | 2010-09-15 | — | — | EP | disclosed |
| WO-2009090566-A1 | ORAL CARE DELIVERY SYSTEM WITH MICROCRYSTALLINE WAX | THE PROCTER & GAMBLE COMPANY (US) | 2009-07-23 | — | — | WO | disclosed |
| US-20090181071-A1 | Oral Care Delivery System with Microcrystalline Wax | THE PROCTER & GAMBLE COMPANY | 2009-07-16 | — | — | US | disclosed |
| EP-1542649-B1 | ORAL PRODUCTS HAVING AN AESTHETIC LAYER | PROCTER & GAMBLE (US) | 2008-04-30 | — | — | EP | disclosed |
| US-6916463-B2 | Oral products having an aesthetic layer | THE PROCTER & GAMBLE COMPANY (US) | 2005-07-12 | — | — | US | disclosed |
| EP-1542649-A1 | ORAL PRODUCTS HAVING AN AESTHETIC LAYER | THE PROCTER & GAMBLE COMPANY (US) | 2005-06-22 | — | — | EP | disclosed |
| WO-2004028499-A1 | ORAL PRODUCTS HAVING AN AESTHETIC LAYER | THE PROCTER & GAMBLE COMPANY (US) | 2004-04-08 | — | — | WO | disclosed |
| US-20040057910-A1 | Oral products having an aesthetic layer | THE PROCTER & GAMBLECOMPANY | 2004-03-25 | — | — | US | disclosed |
| EP-0725630-A1 | FAST DISSOLVING DOSAGE FORMS CONTAINING MAGNESIUM ALUMINUM SILICATE AND MULTIPLE ACTIVE INGREDIENTS | THE PROCTER & GAMBLE COMPANY (US) | 1996-08-14 | — | — | EP | disclosed |
| WO-1995011671-A1 | FAST DISSOLVING DOSAGE FORMS CONTAINING MAGNESIUM ALUMINUM SILICATE AND MULTIPLE ACTIVE INGREDIENTS | THE PROCTER & GAMBLE COMPANY (US) | 1995-05-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090181071-A1 | Oral Care Delivery System with Microcrystalline Wax | MCRS1, TAS2R39, MRPS27 | ALDH1A1 4466/4885LMNA 1402/4885MEN1 2371/4885 |
| US-20040057910-A1 | Oral products having an aesthetic layer | CUTA, LPL, SUCLG1 | ALDH1A1 386/4885LMNA 1368/4885MEN1 3713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.